posted
Anyone familiar with this one? Someone told me I might want to check this out, they release financials on Monday but I don’t know if I will have time to research this today.
IP: Logged |
Search News: Advanced Search Show Headlines SAN FRANCISCO (MarketWatch) -- EpiCept Corp.'s share price more than doubled Friday morning, rising $2.42 to $4.71, after the company reported that studies characterizing a dual mode of action for Azixa, a compound licensed by EpiCept to Myriad Genetics Inc. for the treatment of primary and secondary brain tumors, were presented at the annual meeting of the American Association of Cancer Research in Los Angeles, California. According to EpiCept, the findings presented by Myriad indicate the potential of Azixa to act as a vascular disrupting agent, in addition to its apoptosis inducing capabilities. Vascular disruption of a tumor's endothelium, the inner layer of cells lining a blood vessel, leads to a loss of blood supply to the tumor and subsequent tumor cell death. EpiCept is based in Tarrytown, N.Y.
-
I dont understand what the heck that says except it kills brain tumors?
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
![[Wink]](wink.gif)
